Kidney Transplantation
📧 Sign up to get email alerts when something new happens for Kidney Transplantation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-04Clinical Trial Update: Renal Function Evaluation After Reduction of Cyclosporine A Dose in Renal Transplant Patients [Phase 3]
Phase 3 clinical trial evaluating renal function after reducing cyclosporine A dose in renal transplant patients; completed study.
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: COVID Protection After Transplant-Immunosuppression Reduction [Phase 2]
Phase 2 trial evaluating whether reducing transplant-immunosuppression around COVID-19 exposure provides protection for kidney and liver tra…
-
CLINICAL_TRIALS trial_result · 2026-04-23Clinical Trial Update: Use of Predigraft in Kidney Transplant Patients [NA]
This entry reports the completion of a clinical trial evaluating Predigraft in kidney transplant patients.
-
CLINICAL_TRIALS trial_result · 2026-04-21Clinical Trial Update: Empagliflozin Treatment in Kidney Transplant Recipients [Phase 4]
Phase 4 clinical trial evaluating empagliflozin in kidney transplant recipients is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: Study to Compare the Safety and Efficacy of Sirolimus (Rapamune) to Tacrolimus (Advagraf) Associated to Mycophenolate Mofetil (CellCept) Between 12 and 36 Months After Kidney Transplantation [Phase 3]
Phase 3 clinical trial comparing sirolimus plus mycophenolate mofetil to tacrolimus plus mycophenolate mofetil in kidney transplant recipien…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-04-03Clinical Trial Update: Subcutaneous Abatacept in Renal Transplant Recipients [Phase 1]
Phase 1 study evaluating subcutaneous abatacept in kidney transplant recipients has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: Dose-adjustment of Enoxaparin by a Bayesian Pharmacological Approach in Pediatric Kidney Transplant Recipients (OPTI-TREX) [Phase 4]
Phase 4 trial evaluating dose-adjustment of enoxaparin in pediatric kidney transplant recipients using a Bayesian pharmacological approach; …
-
CLINICAL_TRIALS trial_result · 2026-03-23Clinical Trial Update: Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Kidney Transplant Recipients [Phase 2]
Phase 2 study evaluating CFZ533 (iscalimab), an anti-CD40 monoclonal antibody, in kidney transplant recipients to assess efficacy, safety, t…
-
CLINICAL_TRIALS trial_result · 2026-03-20Clinical Trial Update: The Role of ImmuKnow® in the Management of Immunosuppressants in the Renal Transplant Patient [Phase 4]
A Phase 4 clinical trial evaluating the use of ImmuKnow to guide immunosuppressant management in kidney transplant recipients was terminated…
-
CLINICAL_TRIALS trial_result · 2026-02-27Clinical Trial Update: ABO- or HLA- Incompatible LDKT Compared to Waitlist/DDKT in Elderly Patients
This completed clinical trial from Seoul National University Hospital compares ABO- or HLA-incompatible living-donor kidney transplantation …
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: Study to Compare the Efficacy and Safety After Conversion to RaparoBell® or My-Rept® in Kidney Transplant Patients [Phase 4]
Phase 4 trial evaluating the efficacy and safety after conversion to RaparoBell or My-Rept in kidney transplant patients. The study is curre…
-
CLINICAL_TRIALS trial_result · 2026-02-13Clinical Trial Update: Tolerance by Engaging Antigen During Cellular Homeostasis [Phase 1]
Phase 1 clinical trial update from NIAID evaluating a tolerance-inducing approach called 'Tolerance by Engaging Antigen During Cellular Home…
-
CLINICAL_TRIALS trial_result · 2026-02-06Clinical Trial Update: A Study of TCD601 in the Induction of Tolerance in Renal Transplantation (PANORAMA) [Phase 2]
Phase 2 PANORAMA study evaluating TCD601 for inducing tolerance in kidney transplant recipients has been terminated.
-
CLINICAL_TRIALS trial_result · 2026-01-27Clinical Trial Update: Velocity-Based Resistance Training in Kidney Transplant Recipients [NA]
A clinical trial (NCT07370727) sponsored by Fundación Universitaria del Area Andina is currently recruiting to evaluate velocity-based resis…
-
CLINICAL_TRIALS trial_result · 2026-01-16Clinical Trial Update: Erector Spınae Plane Block and Transmuscular Quadratus Lumborum Block In Kıdney Transplantatıon [NA]
A completed clinical trial evaluated the use of erector spinae plane block and transmuscular quadratus lumborum block for patients undergoin…
-
CLINICAL_TRIALS trial_result · 2026-01-15Clinical Trial Update: Phase I/II Study of FR104 First Administration In Patient With Renal Transplantation: FIRsT Study [Phase 1, Phase 2]
A Phase I/II study (FIRsT) of FR104 in kidney transplantation has completed its Phase 1/Phase 2 activities, including first administration i…
-
CLINICAL_TRIALS trial_result · 2026-01-13Clinical Trial Update: Whole Body Vibration Versus Aerobic Training on Interleukin 6 and Endurance After Renal Transplantation [NA]
A completed clinical trial compared whole body vibration versus aerobic training and assessed Interleukin 6 levels and endurance in kidney t…
-
CLINICAL_TRIALS trial_result · 2026-01-12Clinical Trial Update: Use of DNA Testing to Help Transition Kidney Transplant Recipients to Belatacept-only Immunosuppression [Phase 4]
Phase 4 trial update reporting completion of a study evaluating DNA testing to guide transition of kidney transplant recipients to belatacep…
-
CLINICAL_TRIALS trial_result · 2026-01-08Clinical Trial Update: Thread Embedding Acupuncture vs Sham on Acute Pain and Quality of Life After Laparoscopic Nephrectomy of Living Donor [NA]
A completed clinical trial comparing thread embedding acupuncture versus sham for acute postoperative pain and quality of life after laparos…
-
CLINICAL_TRIALS trial_result · 2025-12-31Clinical Trial Update: Evaluation of the Safety of Use of Anti-IL6 Receptor Antibodies to Reduce Allo-sensitization Post Allograft Nephrectomy [Phase 2]
A completed Phase 2 trial evaluated the safety of anti-IL-6 receptor antibodies to reduce allo-sensitization after kidney allograft nephrect…
-
CLINICAL_TRIALS trial_result · 2025-12-24Clinical Trial Update: Contrast-Enhanced Ultrasound for Kidney Transplant [Phase 1]
Phase 1 trial evaluating contrast-enhanced ultrasound for kidney transplantation has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: The Effects of Vonoprazan Fumarate on DGF Incidence in DD Kidney Transplant Recipients [Phase 1, Phase 2]
Clinical trial update examining whether vonoprazan fumarate influences delayed graft function in kidney transplant recipients; the study is …
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: Metabolomics in Assessing the Quality of Kidney Transplants Retained on a LifePort® Perfusion Machine [NA]
This clinical trial from University Hospital, Tours investigates metabolomics for assessing the quality of kidney transplants preserved on a…
-
CLINICAL_TRIALS trial_result · 2025-11-21Clinical Trial Update: A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients [Phase 2]
Phase 2 study evaluating the efficacy and safety of ASKP1240 in de novo kidney transplant recipients has completed.
-
CLINICAL_TRIALS trial_result · 2025-11-20Clinical Trial Update: Feasibility of Magnetic-end Double-J Ureteral Stent Use in Children [NA]
A completed clinical trial evaluating the feasibility of magnetic-end double-J ureteral stents in pediatric patients with uropathy or kidney…